Andreas F Mavrogenis
Overview
Explore the profile of Andreas F Mavrogenis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
444
Citations
4046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masunaga T, Tsukamoto S, Honoki K, Fujii H, Kido A, Akahane M, et al.
SICOT J
. 2025 Mar;
11:16.
PMID: 40079610
Introduction: Dedifferentiated chondrosarcoma (DDCS) is a high-grade subtype of chondrosarcoma with a poor prognosis. Treatment for localized DDCS generally involves wide resection; the effectiveness of adjuvant radiotherapy and chemotherapy is...
2.
Mitrogiannis G, Gkaintes O, Garnavos C, Potsika V, Roumpi M, Gkiatas I, et al.
Biomed Phys Eng Express
. 2024 Nov;
11(1).
PMID: 39612514
. Open reduction internal fixation (ORIF) and external fixation are traditional surgical techniques for treating type VI Schatzker tibial plateau fractures. A newly developed technique integrates the intramedullary tibial nail...
3.
Masunaga T, Tsukamoto S, Honoki K, Fujii H, Kido A, Akahane M, et al.
SICOT J
. 2024 Nov;
10:46.
PMID: 39513643
Introduction: Mesenchymal chondrosarcoma (MCS) is a malignant, biphasic, high-grade, primitive mesenchymal tumor that has a well-differentiated, organized hyaline component. MCS has a poor prognosis, and treatment recommended for localized MCS...
4.
Dania V, Stavropoulos N, Gavriil P, Trikoupis I, Koulouvaris P, Savvidou O, et al.
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459462
: Tenosynovial giant cell tumor (TGCT) is a rare, locally aggressive, benign neoplasm arising from the synovium of joints, tendon sheaths, and bursa. There are two main subtypes of TGCT:...
5.
Mavrogenis A, Papadimos T, Saranteas T, Hernigou P, Scarlat M
Int Orthop
. 2024 Oct;
48(12):3019-3027.
PMID: 39436483
No abstract available.
6.
Errani C, Atherley OMeally A, Tsukamoto S, Mavrogenis A, Tanaka Y, Manfrini M
SICOT J
. 2024 Oct;
10:38.
PMID: 39364963
Introduction: Limb salvage surgery in children following bone sarcoma resection is a challenging problem because of the small size of the bones, the lack of appropriate size-matched implants, and the...
7.
Mavrogenis A, Hernigou P, Scarlat M
Int Orthop
. 2024 Aug;
48(9):2277-2282.
PMID: 39160384
No abstract available.
8.
Minami N, Tsukamoto S, Shimizu T, Honoki K, Hasegawa H, Masunaga T, et al.
SICOT J
. 2024 Aug;
10:27.
PMID: 39137795
Introduction: To prevent infection after limb-sparing surgery for primary malignant bone tumors, it is important to cover the megaprosthesis with muscle tissue that has sufficient blood flow. Coverage with a...
9.
Altsitzioglou P, Avgerinos K, Karampikas V, Gavriil P, Vlachos A, Soucacou F, et al.
SICOT J
. 2024 Jun;
10:24.
PMID: 38847648
Background: Periprosthetic joint infection (PJI) remains a major complication following total joint arthroplasties (TJA), significantly affecting patient outcomes and healthcare costs. Despite advances in diagnostic techniques, challenges persist in accurately...
10.
Altsitzioglou P, Zafeiris I, Soucacos F, Limneos P, Soulioti E, Mitsiokapa E, et al.
J Long Term Eff Med Implants
. 2024 Jun;
34(4):71-81.
PMID: 38842235
A thorough literature search was done in PubMed and Google Scholar as well as in physical books in libraries to summarize the literature on the history and evolution of medicine...